Inventor
CHAPMAN DENNIS
GB18 patents
⚠️ This page may combine multiple inventors who share the name “CHAPMAN DENNIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIOCOMPATIBLES LTD
6 patentsUS4675310AJun 23, 1987
Liposome composition as gas transport agents
BIOCOMPATIBLES LTD93 citations96
US4689386AAug 25, 1987
Biocompatible surfaces
BIOCOMPATIBLES LTD33 citations89
US4721800AJan 26, 1988
Biocompatible surfaces
BIOCOMPATIBLES LTD21 citations81
US5380904AJan 10, 1995
Process for rendering a surface biocompatible, and articles containing the same
BIOCOMPATIBLES LTD14 citations72
US5229162AJul 20, 1993
Article having biocompatible surface
BIOCOMPATIBLES LTD12 citations72
US5091551AFeb 25, 1992
Trialkyl-O-(W-aminoalkyl)-phosphatidylalkylammonium salts useful for the manufacture of biocompatible surfaces
BIOCOMPATIBLES LTD10 citations72
ARENA PHARM INC
6 patentsUS9328107B2May 3, 2016
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC12 citations92
USRE45337EJan 13, 2015
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC11 citations92
USRE45336EJan 13, 2015
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC12 citations92
US9221755B2Dec 29, 2015
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC11 citations83
US9987252B2Jun 5, 2018
Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC1 citations62
US10450276B2Oct 22, 2019
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
ARENA PHARM INC0 citations51
TEEGARDEN BRADLEY
4 patentsUS8664258B2Mar 4, 2014
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY14 citations91
US8148417B2Apr 3, 2012
Primary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY21 citations91
US8148418B2Apr 3, 2012
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY16 citations91
US8680119B2Mar 25, 2014
Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
TEEGARDEN BRADLEY11 citations82